Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Immunotherapy Advances|September 20, 2021
A glutamine 'tug-of-war': targets to manipulate glutamine metabolism for cancer immunotherapyLaura J Pallett, Sarah Dimeloe, Linda V Sinclair, et al.
Immunotherapy Advances|August 3, 2022
HBV-HCC treatment with mRNA electroporated HBV-TCR T cellsAnthony T Tan, Antonio Bertoletti
Immunotherapy Advances|August 3, 2022
Balancing the good and the bad: controlling immune-related adverse events versus anti-tumor responses in cancer patients treated with immune checkpoint inhibitorsGuilherme Ferreira de Britto Evangelista, Amanda Braga Figueiredo, Milton José de Barros E Silva, et al.
Immunotherapy Advances|August 3, 2022
Integrin-directed antibody-based immunotherapy: focus on VLA-4Wilson Savino, Beatriz Chaves, Adriana Cesar Bonomo, et al.
Immunotherapy Advances|August 3, 2022
Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunityNaomi Richardson, David Cameron Wraith
Immunotherapy Advances|August 3, 2022
Potential human immunotherapeutics for plagueVoahangy Andrianaivoarimanana, Lovasoa Nomena Randriantseheno, Kristoffer M Moore, et al.
Immunotherapy Advances|August 3, 2022
α2-3 Sialic acid binding and uptake by human monocyte-derived dendritic cells alters metabolism and cytokine release and initiates tolerizing T cell programmingJoyce Lübbers, Rui-Jún Eveline Li, Friederike S Gorki, et al.
Immunotherapy Advances|July 11, 2022
Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?Tamiko R Katsumoto, Kalin L Wilson, Vinay K Giri, et al.
Immunotherapy Advances|July 22, 2021
Type 2 immunity is maintained during cancer-associated adipose tissue wastingPatrick J Lenehan, Assunta Cirella, Amiko M Uchida, et al.
Immunotherapy Advances|March 30, 2026
Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort studyOliver John Kennedy, Rebecca Lee, Fiona Blackhall, et al.
Pageof 16